In a nationwide cohort study, with more than 440,000 doses of human papillomavirus (HPV) vaccines administered to young women, no evidence was found to support an association between HPV vaccination and serious adverse events using both cohort analysis and self-controlled risk interval analysis.
Pregnant Women May Pass COVID-19 Antibody Protection to Infants Before Delivery
A study published by JAMA Pediatrics demonstrates maternally derived antibodies’ potential to provide neonatal protection from SARS-CoV-2 infection.
This study’s findings indicate an ‘efficient transplacental transfer of SARS-CoV-2 IgG antibodies supports the potential for maternally derived antibodies to provide neonatal protection from SARS-CoV-2 infection.’
These researchers stated on January 29, 2021, ‘Our findings align with current evidence that suggests that although placental and neonatal SARS-CoV-2 transmission may occur, such events are not common.’